Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Stroke Recovery (EFFECTS)
NCT02683213Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Oct 2014
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluoxetine in stroke, sponsored by Karolinska Institutet. Started Oct 2014; status: completed.
02
Drugs
fluoxetine
03
Conditions
stroke
Beyond the preview
Go deeper on NCT02683213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683213.